COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,832 Articles (22,553 medRxiv, 8,279 bioRxiv)

Most recent first Previous |  Page 1675: Articles 16741-16750  | Next

Comparing COVID-19 risk factors in Brazil using machine learning: the importance of socioeconomic, demographic and structural factors
Baqui, P., Marra, V., Alaa, A. M., Bica, I., Ercole, A., van der Schaar, M.
10.1101/2021.03.11.21253380 — Posted: 2021-03-12 Discussion: Onsite
Leg-heel chest compression as an alternative for medical professionals in times of COVID-19
Ott, M., Krohn, A., Bilfield, L. H., Dengler, F., Jaki, C., Echterdiek, F., Schilling, T., Heymer, J.
10.1101/2021.03.09.21253220 — Posted: 2021-03-12
Comparison of SARS-CoV-2 detection in Saliva by real-time RT-PCR and RT-PCR/MALDI-TOF Methods
Hernandez, M. M., Banu, R., Shrestha, P., Patel, A., Chen, F., Cao, L., Fabre, S., Tan, J., Lopez, H., Chiu, N., Shifrin, B., Zapolskaya, I., Flores, V., Lee, P. Y., Castaneda, S., Ramirez, J. D., Jhang, J., Osorio, G., Gitman, M. R., Nowak, M. D., Reich, D. L., Cordon-Cardo, C., Sordillo, E. M., Paniz Mondolfi, A. E.
10.1101/2021.03.11.21253234 — Posted: 2021-03-12
Recovered not restored: Long-term health consequences after mild COVID-19 in non-hospitalized patients
Augustin, M., Schommers, P., Stecher, M., Dewald, F., Gieselmann, L., Gruell, H., Horn, C., Vanshylla, K., Di Cristianziano, V., Osebold, L., Roventa, M., Riaz, T., Tschernoster, N., Altmueller, J., Rose, L., Salomon, S., Priesner, V., Luers, J. C., Albus, C., Rosenkranz, S., Gathof, B., Faetkenheuer, G., Hallek, M., Klein, F., Suarez, I., Lehmann, C.
10.1101/2021.03.11.21253207 — Posted: 2021-03-12 Discussion: Onsite
An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status
Lumley, S. F., Rodger, G., Constantinides, B., Sanderson, N., Chau, K. K., Street, T. L., O'Donnell, D., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., Peck, L. J., Ritter, T. G., de Toledo, Z., Warren, L., Axten, D., Cornall, R. J., Jones, E. Y., Stuart, D. I., Screaton, G., Ebner, D., Hoosdally, S., Chand, M., Oxford University Hospitals Staff Testing Group, , Crook, D., O'Donnell, A.-M., Conlon, C. P., Pouwels, K. B., Walker, A. S., Peto, T. E., Hopkins, S., Walker, T. M., Stoesser, N. E., Matthews, P. C., Jeffery, K., Eyre, D. W.
10.1101/2021.03.09.21253218 — Posted: 2021-03-12 Discussion: Onsite | Offsite
SARS-CoV-2 specific immune-signature in direct contacts of COVID-19 cases protect them from contracting disease: A Retrospective Study
Raghav, S. K., Sen, K., Ghosh, A., Datta, S., Ahad, A., Jha, A., Chatterjee, S., Suranjika, S., Sengupta, S., Bhattacharya, G., Shriwas, O., Avula, K., Kshatri, J., Prasad, P., Parida, A. K.
10.1101/2021.03.11.21253367 — Posted: 2021-03-12
Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics
Stoddard, M., Yuan, L., Chakravarty, A.
10.1101/2021.03.11.21253375 — Posted: 2021-03-12
Natural spring water gargle and direct RT-PCR for the diagnosis of COVID-19 (COVID-SPRING study)
Dumaresq, J., Coutlee, F., Dufresne, P., Longtin, J., Fafard, J., Bestman-Smith, J., Bergevin, M. A., Vallieres, E., Desforges, M., Labbe, A.-C.
10.1101/2021.03.11.21251938 — Posted: 2021-03-12
Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape
Santos, K. S., Oliveira, J. R., Machado, R. R., Magawa, J. Y., Daher, I. P., Urbanski, A. H., Schmitz, G. J., Silva, R. C. V., Durigon, E. L., Boscardin, S. B., Rosa, D. S., Schechtman, D., Nakaya, H. I., Cunha-Neto, E., Gadermaier, G., Coelho, V., Kalil, J.
10.1101/2021.03.11.21253399 — Posted: 2021-03-12
A rapid review of COVID-19 vaccine prioritization in the U.S.: alignment between Federal guidance and State practice
Jain, V., Schwarz, L., Lorgelly, P.
10.1101/2021.03.11.21253411 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).